Estimates Revisions Evotec SE Deutsche Boerse AG
Stocks
EVTA
US30050E1055
Biotechnology & Medical Research
|
Delayed
Deutsche Boerse AG
09:08:54 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.260 EUR | -5.26% |
|
-5.97% | -52.27% |
| 09-18 | Evotec at the top of the SDax - Positive comments at a conference | DP |
| 09-09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Evotec SE(EVT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Evotec SE(EVT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Evotec SE(EVT)
EBIT
Dividend / Share (DPS)
Data source:
Evotec SE(EVT)
Cash or Net Debt
- Stock Market
- Stocks
- EVT Stock
- EVTA Stock
- Consensus Evotec SE
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
